查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1715515

脊髓刺激市场依产品类型、适应症、通路和最终用途划分－2025-2030 年全球预测

Spinal Cord Stimulation Market by Product Type, Indication, Distribution Channel, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计脊髓刺激市场在 2023 年的价值将达到 26.1 亿美元，在 2024 年增长至 29.5 亿美元，到 2030 年将达到 65.1 亿美元，复合年增长率为 13.93%。

主要市场统计数据
基准年2023年 26.1亿美元
预计2024年 29.5亿美元
预测年份 2030 65.1亿美元
复合年增长率（%） 13.93%

近年来，脊髓刺激已成为先进疼痛管理和神经调节疗法的关键方面。技术创新为治疗慢性和顽固性疼痛提供了广泛的解决方案，推动了市场的稳定成长。本介绍将在此基础上探讨脊髓刺激设备的发展、其不断扩大的临床应用以及持续改变医疗保健格局的潜在趋势。

脊髓刺激因其在治疗复杂疼痛综合征方面的有效性而迅速引起临床医生和决策者的注意。随着对微创手术和改善患者治疗效果的日益重视，设备功能和营运效率的策略进步对市场发展势头做出了重大贡献。了解临床创新、技术进步和以患者为中心的设计之间的相互作用对于利用该领域的新兴机会至关重要。

本报告对市场区隔、区域动态以及推动此转变的主要企业提供了全面的见解。本介绍性概况为相关人员提供了一个简洁而强大的框架，以了解当今影响脊髓刺激疗法的多方面因素。

改变脊髓刺激市场

最近的转型转变重新定义了脊髓刺激市场，开创了一个以创新和不断变化的患者期​​望为标誌的新时代。设备设计、能源效率和无线连接的进步促进了患者护理和手术结果的改善。这些技术不仅简化了业务工作流程，也为更个人化的治疗方法铺平了道路。

在研究投入增加、监管支持以及神经调节技术更广泛接受的推动下，市场正在经历重大重组。随着临床界倾向于实证实践，人们明显地从传统的疼痛管理疗法转向更有针对性的、以治疗为中心的方法。将工程创新与临床专业知识结合在一起的跨学科合作进一步推动了这一转变。相关人员现在可以更好地利用这些进步并确保治疗方案始终处于患者照护的最前沿。

此外，数位化整合的势头正在提供即时数据分析和改进的回馈机制，从而改变手术前和手术后的监测。这些变化强调了适应性策略对于产业参与者的重要性，并强调了持续创新对于在不断变化的环境中保持竞争力的关键作用。

脊髓刺激市场的关键细分洞察

深入研究市场区隔可以发现一个复杂的框架，这对于理解脊髓刺激市场的多样化动态至关重要。根据产品类型进行细分主要关注从不可充电到可充电系统的设备，每种设备在寿命、维护要求和患者相容性方面都具有独特的优势。技术设计的多样性对市场采用产生了重大影响，可充电系统因其长期成本效益和便利性而越来越受到青睐。

当考虑适应症时，市场表现出根据临床症状分类的不同子区隔，例如复杂性局部疼痛症候群、背部手术失败综合征和缺血性肢体疼痛。这些病理不仅决定了技术应用的特殊性，而且强调了需要客製化解决方案来有效解决特定的疼痛管理挑战。基于适应症的方法有助于确定患者的特定需求并衡量一系列疼痛状况的治疗成功率。

此外，从销售管道角度的洞察凸显了线下（传统医疗机构）和线上平台之间的差异，这些平台最近开始在设备传播和知情患者决策中发挥关键作用。由于分销管道和最终用途之间的相互作用，市场进一步细分为门诊手术室、诊所和医院，每个领域都有不同的需求和业务效率。这些细分洞察的整合提供了市场力量如何相互作用和发展的清晰图景，使行业专家能够根据细微的市场需求量身定制他们的策略。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 腰椎手术失败症候群和椎间盘退化性疾病（DDD）的发生率不断上升
      • 有利的公私合营努力和新设备核准的增加
    • 限制因素
      • SCS 设备和程序高成本且替代疗法可用性低
    • 机会
      • 增加对研发的投资和资金，以开发更好、更有效的SCS技术
      • 脊髓刺激装置的技术不断进步
    • 任务
      • 对设备故障风险和脊髓刺激治疗副作用的担忧
  • 市场区隔分析
    • 产品类型：由于设备寿命更长，可充电系统越来越受欢迎
    • 适应症：腰椎手术失败症候群的发生率不断上升，导致脊髓刺激治疗的需求增加
    • 最终使用者：医院中脊髓刺激装置的使用日益增多
    • 分销管道：日益增长的可及性和便利性正在推动消费者对线上分销管道的偏好
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 脊髓刺激市场（依产品类型）

  • 不可充电系统
  • 可充电系统

第七章脊髓刺激市场（按适应症）

  • 复杂性局部疼痛症候群
  • 背部手术失败综合症
  • 缺血性肢体疼痛

第 8 章脊髓刺激市场（依通路）

  • 离线
  • 在线的

9. 脊髓刺激市场（依最终用途）

  • 门诊手术部
  • 诊所
  • 医院

10.美洲脊髓刺激市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太脊髓刺激市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12.欧洲、中东和非洲脊髓刺激市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Abbott Laboratories
  • Axonics, Inc.
  • Beijing PINS Medical Co., Ltd
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Gimer Medical Co., Ltd.
  • Helius Medical Technologies, Inc.
  • Mainstay Medical Limited
  • Medtronic PLC
  • Nalu Medical, Inc.
  • Nevro Corp.
  • Rishena Co., Ltd.
  • Saluda Medical Pvt. Ltd.
  • Soterix Medical, Inc.
  • Teliatry, Inc.
  • WISE SpA
Product Code: MRR-0309FBC512F4

The Spinal Cord Stimulation Market was valued at USD 2.61 billion in 2023 and is projected to grow to USD 2.95 billion in 2024, with a CAGR of 13.93%, reaching USD 6.51 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 2.61 billion
Estimated Year [2024] USD 2.95 billion
Forecast Year [2030] USD 6.51 billion
CAGR (%) 13.93%

In recent years, the field of spinal cord stimulation has emerged as a pivotal aspect of advanced pain management and neuromodulation therapies. The market has witnessed steady growth as technological innovations have provided a wider array of solutions to manage chronic and refractory pain conditions. This introduction lays the groundwork by exploring the evolution of spinal cord stimulation devices, the expanding clinical applications, and the underlying trends that continue to reshape the healthcare landscape.

Spinal cord stimulation has rapidly gained attention among clinical practitioners and decision-makers alike owing to its efficacy in addressing complex pain syndromes. With increasing emphasis on minimally invasive procedures and enhanced patient outcomes, strategic advancements in device functionality and operational efficiency have contributed significantly to market momentum. Understanding the interplay between clinical innovation, technological advancements, and patient-centric design is essential for capitalizing on emerging opportunities in this space.

The narrative that follows encapsulates comprehensive insights into market segmentation, regional dynamics, and influential companies driving this transformation. This introductory overview provides a concise yet robust framework for stakeholders to appreciate the multi-faceted elements influencing the spinal cord stimulation landscape today.

Transformative Shifts in the Spinal Cord Stimulation Landscape

Recent transformative shifts have redefined the spinal cord stimulation market, bringing forth a new era marked by innovation and evolving patient expectations. Advancements in device design, energy efficiency, and wireless connectivity have catalyzed improvements in both patient management and procedural outcomes. These technologies have not only streamlined operational workflows in clinical settings but have also paved the way for more personalized treatment approaches.

The market has experienced significant realignments driven by increased research investments, regulatory support, and a broader acceptance of neuromodulation techniques. As the clinical community leans towards evidence-based practices, there has been a remarkable shift from conventional pain management therapies to more targeted, therapy-centric approaches. This shift has been further accelerated by interdisciplinary collaborations that integrate engineering innovations with clinical expertise. Stakeholders are now better positioned to harness these advancements, ensuring that therapeutic solutions remain at the forefront of patient care.

Moreover, the momentum in digital integration is transforming pre-procedural and post-procedural monitoring, offering real-time data analysis and improved feedback mechanisms. These changes underscore the importance of adaptive strategies for industry players and highlight the critical role of continuous innovation in maintaining a competitive edge within this evolving landscape.

Key Segmentation Insights for Spinal Cord Stimulation Market

A deep dive into market segmentation reveals a complex framework that is crucial for understanding the diverse dynamics of the spinal cord stimulation market. The segmentation based on product type focuses on devices ranging from non-rechargeable systems to rechargeable systems, each offering unique benefits in terms of longevity, maintenance requirements, and patient adaptability. Variations in technological design have had a profound impact on market adoption, with rechargeable systems increasingly preferred for their longer-term cost effectiveness and convenience.

When examining indications, the market presents distinct sub-segments classified by clinical conditions such as complex regional pain syndrome, failed back surgery syndrome, and ischemic limb pain. These conditions not only dictate the specificity of technological applications but also emphasize the need for tailored solutions that address particular pain management challenges effectively. The indication-based approach helps in pinpointing specific patient needs and measuring therapeutic success over a diverse range of pain disorders.

Furthermore, insights from the distribution channel perspective underscore the differences between offline (traditional healthcare facilities) and online platforms that have recently started playing a critical role in device dissemination and informed patient decision-making. The interplay between distribution channels and end-use further segments the market into ambulatory surgical units, clinics, and hospitals, each of which has varying demands and operational efficiencies. Integrating these segmentation insights provides a clear picture of how market forces interact and evolve, enabling industry experts to align their strategies with nuanced market requirements.

Based on Product Type, market is studied across Non-Rechargeable Systems and Rechargeable Systems.

Based on Indication, market is studied across Complex Regional Pain Syndrome, Failed Back Surgery Syndrome, and Ischemic Limb Pain.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End-Use, market is studied across Ambulatory Surgical Units, Clinics, and Hospitals.

Comprehensive Regional Dynamics in the Spinal Cord Stimulation Sector

Exploring the regional landscape, it is evident that market dynamics vary considerably across different geographies. In the Americas, the spinal cord stimulation market has benefitted from extensive clinical research and a robust healthcare infrastructure that supports rapid adoption of innovative therapies. The region's mature market base and proactive insurers further drive the uptake of advanced neuromodulatory solutions.

In Europe, the Middle East and Africa, growing awareness and evolving regulatory pathways continue to foster significant investments in research and development. This unique blend of stringent regulatory standards with emerging market conditions is shaping a competitive environment that challenges established treatment paradigms while fostering localized innovations. The emphasis on quality, safety, and cost-effectiveness in these regions has led to a broader acceptance of spinal cord stimulation technologies in both urban and rural clinical settings.

Asia-Pacific, with its dynamic growth and rapidly expanding healthcare sector, stands out as one of the most promising regions for spinal cord stimulation. The convergence of increasing patient awareness, heightened focus on non-invasive therapies, and supportive government initiatives has catalyzed market growth. These regional insights highlight considerable heterogeneity in market maturity, patient demographics, and regulatory frameworks that collectively influence the deployment and effectiveness of spinal cord stimulation therapies across the globe.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Industry Players and Market Leaders in Spinal Cord Stimulation

The landscape of spinal cord stimulation is characterized by robust competition among leading industry players, each of whom contributes to the market's evolution through technological innovation and strategic partnerships. Over the years, companies such as Abbott Laboratories and Axonics, Inc. have established themselves as pioneers with a strong focus on clinical efficacy and sustainability. Their commitment to advancing neuromodulation solutions has set benchmarks for the industry.

Other significant players like Beijing PINS Medical Co., Ltd and BIOTRONIK SE & Co. KG bring a combination of engineering excellence and clinical expertise to the market, while Boston Scientific Corporation and Gimer Medical Co., Ltd. continue to widen the scope of pain management through transformative device portfolios. Helius Medical Technologies, Inc., Mainstay Medical Limited, and Medtronic PLC further underscore the intense competitive landscape by investing in next-generation technologies that enhance patient experiences and improve long-term clinical outcomes.

Emerging innovators such as Nalu Medical, Inc. and Nevro Corp. play a pivotal role in driving technological disruption, complemented by the strategic initiatives of Rishena Co., Ltd., Saluda Medical Pvt. Ltd., and Soterix Medical, Inc. Their collaborative efforts, research breakthroughs, and sustained market presence indicate a robust commitment to reimagining therapeutic paradigms. In addition, Teliatry, Inc. and WISE SpA have contributed to a diversified and resilient portfolio of solutions that respond effectively to the evolving clinical demands of spinal cord stimulation. Together, these companies shape a competitive environment that continues to push the envelope of technological advancement and best-in-class patient care.

The report delves into recent significant developments in the Spinal Cord Stimulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Axonics, Inc., Beijing PINS Medical Co., Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Gimer Medical Co., Ltd., Helius Medical Technologies, Inc., Mainstay Medical Limited, Medtronic PLC, Nalu Medical, Inc., Nevro Corp., Rishena Co., Ltd., Saluda Medical Pvt. Ltd., Soterix Medical, Inc., Teliatry, Inc., and WISE SpA. Strategic Actionable Recommendations for Industry Leaders

For industry leaders seeking to capitalize on new opportunities in the spinal cord stimulation market, a strategic, multifaceted approach is essential. Emphasizing research and development is paramount, with a focus on integrating advanced digitalization efforts and hybrid models of device management. Leaders should prioritize investment in technologies that enhance device functionality, robustness, and patient usability, while also ensuring rigorous compliance with evolving regulatory standards.

It is imperative to expand market penetration by establishing strong alliances with healthcare providers and clinical research organizations. Developing differentiated product portfolios tailored to specific pain indications can drive competitive advantages. Decision-makers are encouraged to leverage data analytics to monitor efficacy and optimize patient outcomes, thereby reinforcing long-term trust and credibility with stakeholders.

Furthermore, an adaptive marketing strategy that resonates with both traditional healthcare professionals and digitally engaged consumers will be key. Diversification of distribution channels, including enhanced online platforms alongside established offline networks, can broaden market reach. By nurturing innovation, optimizing operational efficiency, and maintaining agility in response to emerging trends, industry leaders can effectively shape the future trajectory of spinal cord stimulation.

Conclusion and Forward Outlook for Spinal Cord Stimulation

The evolving landscape of spinal cord stimulation presents both challenges and opportunities that call for a strategic, well-informed approach. Over the course of this analysis, it is evident that technological advancements, evolving patient expectations, and robust market segmentation play crucial roles in defining current trends and future trajectories. From transformative shifts in device technology to the nuanced demands of varied geographic regions, the industry stands at a critical juncture where innovation meets clinical necessity.

A comprehensive understanding of market dynamics is imperative for stakeholders who seek sustainable growth. The detailed exploration of segmentation insights and regional dynamics, alongside an evaluation of the competitive player landscape, underscores the importance of adaptability and continuous advancement. With a clear focus on targeted interventions and cutting-edge research, the spinal cord stimulation market is poised to deliver enhanced patient outcomes while driving financial performance.

As the industry continues to evolve, it is crucial for decision-makers to remain adaptive, anticipating emerging trends and aligning strategic initiatives with the latest technological breakthroughs. This forward outlook serves as a clarion call for innovation and excellence in clinical care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of failed back surgery syndrome and degenerative disk disease (DDD)
      • 5.1.1.2. Favorable public-private initiatives and increasing approvals for new device
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of SCS devices and procedures and availability of alternative therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment and funding in research and development for better and more effective SCS technologies
      • 5.1.3.2. Ongoing technological advancements in spinal cord stimulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of device malfunction and concerns associated with adverse effects of spinal cord stimulation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Growing preference for rechargeable systems owing to longer device lifespan
    • 5.2.2. Indication: Rising need for spinal cord stimulation with the growing incidences of failed back surgery syndrome
    • 5.2.3. End-user: Growing utilization of spinal cord stimulation devices in hospitals
    • 5.2.4. Distribution Channel: Increasing consumer preference for online distribution channels owing to greater accessibility and convenience
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spinal Cord Stimulation Market, by Product Type

  • 6.1. Introduction
  • 6.2. Non-Rechargeable Systems
  • 6.3. Rechargeable Systems

7. Spinal Cord Stimulation Market, by Indication

  • 7.1. Introduction
  • 7.2. Complex Regional Pain Syndrome
  • 7.3. Failed Back Surgery Syndrome
  • 7.4. Ischemic Limb Pain

8. Spinal Cord Stimulation Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Spinal Cord Stimulation Market, by End-Use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Units
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Spinal Cord Stimulation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Spinal Cord Stimulation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Spinal Cord Stimulation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wise secures funding to boost development of HERON Lead in spinal cord stimulation
    • 13.3.2. Medtronic recieves FDA approval for Inceptiv closed-loop spinal cord stimulator
    • 13.3.3. FDA approves Boston Scientific's spinal cord stimulator systems for non-surgical back pain relief
    • 13.3.4. The University of Alabama at Birmingham's innovative spinal cord stimulator therapy enhances chronic pain management with real-time adjustments
    • 13.3.5. Abbott recieves FDA Approval for expanded use of spinal cord stimulation systems
    • 13.3.6. Saluda Medical secures USD 150 million funding to transform chronic pain treatment with Evoke system
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Boston Scientific Corporation
    • 13.4.2. Medtronic PLC
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Nevro Corp.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Axonics, Inc.
  • 3. Beijing PINS Medical Co., Ltd
  • 4. BIOTRONIK SE & Co. KG
  • 5. Boston Scientific Corporation
  • 6. Gimer Medical Co., Ltd.
  • 7. Helius Medical Technologies, Inc.
  • 8. Mainstay Medical Limited
  • 9. Medtronic PLC
  • 10. Nalu Medical, Inc.
  • 11. Nevro Corp.
  • 12. Rishena Co., Ltd.
  • 13. Saluda Medical Pvt. Ltd.
  • 14. Soterix Medical, Inc.
  • 15. Teliatry, Inc.
  • 16. WISE SpA

LIST OF FIGURES

  • FIGURE 1. SPINAL CORD STIMULATION MARKET MULTI-CURRENCY
  • FIGURE 2. SPINAL CORD STIMULATION MARKET MULTI-LANGUAGE
  • FIGURE 3. SPINAL CORD STIMULATION MARKET RESEARCH PROCESS
  • FIGURE 4. SPINAL CORD STIMULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINAL CORD STIMULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL CORD STIMULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SPINAL CORD STIMULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. SPINAL CORD STIMULATION MARKET, FPNV POSITIONING MATRIX, 2023